Actively Recruiting
Study of Oral Microbial Transplant Therapy Capsules After Antibiotics in Adults With Recurrent Calcium-Oxalate Kidney Stones
Led by Joshua Stern · Updated on 2026-10-27
20
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
This research is studying adults who have recurrent calcium-oxalate kidney stones and examines whether oral microbial transplant therapy can alter urine factors linked to these stones. The study focuses on adults with high levels of urine calcium or oxalate and aims to assess changes in these urine substances as well as treatment safety. It is an early phase 1, open-label pilot study without randomization or blinding. Participants are divided into two groups based on their urine test results those with high urine oxalate and those with high urine calcium. All participants first receive an antibiotic treatment with vancomycin and neomycin taken orally twice daily for three days. After a 48 to 72 hour break, they take two capsules of microbial transplant therapy daily for seven days. This treatment is followed by collecting urine and stool samples at various points. Participants are monitored throughout the study with weekly contacts until week 5, followed by telephone or record reviews from months 2 to 6, and further record reviews at months 9 and 12. The primary outcomes include changes in 24-hour urinary oxalate and calcium levels from baseline to weeks 1, 3, and 5, and the frequency of adverse events within 30 days after the microbial transplant therapy. Secondary outcomes track changes in the participants microbiota. The total participation period extends up to one year with multiple assessments.
CONDITIONS
Brief Title
Fecal Microbiota Transplantation in Kidney Stone Patients
Research Team
N
Nic Unsworth
J
Joshua Stern, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here